Peng D et al. have recently shown that MDSCs enhance the stemness of breast cancer cells through the production of IL-6 and nitric oxide (NO) and the subsequent activation of STAT3 and Notch signaling pathways, respectively. Here, IL6 is linked to breast cancer.